Staphylococcus Aureus Septicemia: Clinical Trials

5 trials for Staphylococcus Aureus Septicemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 unknown. 3 Phase 4, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 3
Not applicable1Unknown 1
Phase 21Recruiting 1

Follow Staphylococcus Aureus Septicemia: new trials by email Literature Review of Staphylococcus Aureus Septicemia trials Research Report on Staphylococcus Aureus Septicemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Clopidogrel, Aspirin - Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia
Phase 4RecruitingTodd C. Lee MD MPH FIDSA3002026-02-232026-11-12
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Dabigatran, Apixaban, edoxaban - Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia
Phase 4RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre3002026-01-152026-09-24
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Daptomycin for Injection, Vancomycin (IV) - Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia
Phase 4RecruitingTodd C. Lee MD MPH FIDSA3002024-11-142026-09-09
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Ertapenem, Placebo - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia
Phase 2RecruitingTodd C. Lee MD MPH FIDSA602024-05-202026-11-02
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
PET/CT - Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia
Not applicableUnknownUniversity College, London8202023-09-012023-05-15

Narrower conditions

Staphylococcal Infections (2)  ·  Bacteremia (1)  ·  Sepsis (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Sepsis (1)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  Dabigatran (1)  ·  Daptomycin (1)  ·  Ertapenem (1)  ·  Injections (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Rivaroxaban (1)  ·  Vancomycin (1)  ·  apixaban (1)  ·  edoxaban (1)

Sponsors

Todd C. Lee MD MPH FIDSA (3)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  University College, London (1)

Countries

Canada (4)  ·  Australia (1)  ·  New Zealand (1)

Top investigators

Todd C Lee, MD MPH FIDSA (3)  ·  Emily G McDonald, MD MSc (2)  ·  Anna Goodman (1)  ·  Emily G McDonald, MD MSC (1)  ·  Matthew P Cheng, MD (1)

Results publications

PMID 41387009, PMID 41433510

NIH funding

2025 (3)